Biosimilars Market 2020-2025: Current Status, Various Services, High Growth, Market Segmentation, Major Countries & Business Outlook

1
Biosimilars Market

• Size 2018, By Product (Recombinant
  Non-glycosylated Proteins, Recombinant
  Glycosylated Proteins, Recombinant Peptides) Type
  of Manufacturing (In-house Manufacturing,
  Contract Manufacturing) Application (Oncology,
  Blood Disorders, Chronic Diseases, Autoimmune
  Diseases, Growth Hormone Deficiency, Infectious
  Diseases, Other Diseases) Region and Forecast
  2019 to 2025

Single Use License US 4400
Request Sample
2
Global Biosimilars Market To Grow From USD 14.58
Billion In 2018 To USD 107.04 Billion By 2025

• The global biosimilars market is projected to
  reach USD 107.04 billion by 2025, growing at a
  CAGR of 33.2. Increased incidences of chronic
  diseases and cost-effectiveness are driving the
  growth of the biosimilars market.
• Adroit Market Research report on global
  biosimilars market gives a holistic view of the
  market from 2015 to 2025, which includes factors
  such as market drivers, restraints, opportunities
  and challenges. The market has been studied for
  historic years from 2015 to 2017, with the base
  year of estimation as 2018 and forecast from 2019
  to 2025. The report covers the current status and
  future traits of the market at global as well as
  country level. In addition, the study also
  assesses the market based on Porter's five forces
  analysis and positions the key players based on
  their product portfolio, geographic footprint,
  strategic initiatives and overall revenue.
  Prominent players operating in the global
  biosimilars market have been studied in detail.
• Biologic medicines have revolutionized the
  treatment of many life-threatening illnesses such
  as cancer and autoimmune diseases as well as many
  rare diseases. Many biologic products can
  actually slow the progress of or even prevent
  disease, leaving healthy cells unaffected and
  generally causing fewer side effects. As
  technology advances and major biologic products
  are no longer under exclusivity, follow-on
  products have begun expanding the biologics
  market considerably. Yet, because of their
  intricate molecular structure and complex
  manufacturing process in living cells, unlike
  generic follow-on products to traditional
  chemical entities, the production and
  manufacturing process of biosimilars cannot
  guarantee that the follow-on products properties
  are identical to those of the reference product.
  For this reason, follow-on products of innovative
  biologic medicines are referred to as biosimilars.

3
Global Biosimilars Market To Grow From USD 14.58
Billion In 2018 To USD 107.04 Billion By 2025

• The global biosimilars market has been segmented
  based on product, type of manufacturing, and
  application. Based on application the market is
  segmented into oncology, blood disorders, chronic
  diseases, autoimmune diseases, growth hormone
  deficiency, infectious diseases and other
  diseases. The blood disorder segment dominated
  the market in 2018.
• Europe was the largest market for biosimilars in
  2018, whereas Asia Pacific is set to register
  highest CAGR during the forecast period. Asia is
  expected to emerge as the fastest growing
  regional market, with developing economies
  expanding at a substantial pace and incorporating
  developments to sustain the competition. Several
  international companies are seeking outsourcing
  of biopharmaceutical production to Asian
  countries owing to continuous expansion of Asian
  Contract manufacturing organizations (CMO) that
  offer services at a reduced price, compared to
  service providers based in western countries.
  There have been several factors contributing to
  the growth of the biologics industry in Asia.
• Key players of the biosimilars market include
  Pfizer, Sandoz International, Teva
  Pharmaceuticals, Amgen, Biocon, Dr. Reddys
  Laboratories, Celltrion and Samsung Biologics
  among others.
• Browse the complete report on _at_
  https//www.adroitmarketresearch.com/industry-repo
  rts/biosimilars-market

4
Segment Overview of Global biosimilars market

• Product Overview, 2015-2025 (USD Billion)
• Recombinant Non-glycosylated Proteins
• Recombinant Glycosylated Proteins
• Recombinant Peptides
• Type of Manufacturing Overview, 2015-2025 (USD
  Billion)
• In-house Manufacturing
• Contract Manufacturing
• Application Overview, 2015-2025 (USD Billion)
• Oncology
• Blood Disorders
• Chronic Diseases
• Autoimmune Diseases
• Growth Hormone Deficiency
• Infectious Diseases
• Other Diseases

5
Segment Overview of Global biosimilars market

• Regional Overview, 2015-2025 (USD Million)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East Africa
• Purchase a single user copy of the global
  biosimilars market report_at_ https//www.adroitmarke
  tresearch.com/researchreport/purchase/72

6
About Us

• Adroit Market Research is an India-based business
  analytics and consulting company. Our target
  audience is a wide range of corporations,
  manufacturing companies, product/technology
  development institutions and industry
  associations that require understanding of a
  markets size, key trends, participants and
  future outlook of an industry. We intend to
  become our clients knowledge partner and provide
  them with valuable market insights to help create
  opportunities that increase their revenues. We
  follow a code Explore, Learn and Transform. At
  our core, we are curious people who love to
  identify and understand industry patterns, create
  an insightful study around our findings and churn
  out money-making roadmaps. Our analysts have
  tracked high growth markets in chemicals
  materials, healthcare pharmaceuticals,
  semiconductor electronics, energy power, food
  retail, consumer goods, technology, and
  machinery equipment sectors across the world to
  identify new opportunities, potential customers,
  prepare go-to-market (GTM) strategies, identify
  segments for revenue growth for companies, and
  many more.

• US Headquarters3131 McKinney Ave Ste 600
  Dallas, TX 75204 ,U.S.A 

• Phone [phone]
• Email sales_at_adroitmarketresearch.com